Related Experiment Video
Updated: Jul 1, 2025
08:28
Experimental Metastasis Assay
Published on: August 24, 2010
20.3K
Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
Luca Dalle Carbonare1, Arianna Minoia1, Anna Vareschi1
1Department of Engineering for Innovative Medicine, University of Verona, 37134 Verona, Italy.
Cells
|March 13, 2024
Summary
The Runt-related transcription factor 2 (RUNX2) promotes melanoma progression by increasing C-X-C motif chemokine receptor 4 (CXCR4) expression. This enhances cell invasion, autophagy, and osteotropism, suggesting CXCR4 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Overexpression of Runt-related transcription factor 2 (RUNX2) is linked to various cancers.
- C-X-C motif chemokine receptor 4 (CXCR4) plays a role in tumor progression.
- The interaction between RUNX2 and CXCR4 in melanoma is not well understood.
Purpose of the Study:
- To investigate the influence of RUNX2 on CXCR4 expression in melanoma cells.
- To assess the effects of RUNX2 and CXCR4 on melanoma cell invasion and autophagy.
- To evaluate the role of RUNX2 and CXCR4 in melanoma osteotropism.
Main Methods:
- Utilized a RUNX2 knockout (RUNX2-KO) in vitro melanoma model.
- Assessed protein levels of RUNX2, CXCR4, and autophagy markers (LC3, beclin).
- Employed a 3D microfluidic model to evaluate osteotropism and analyzed mTOR and p70-S6 signaling.
Main Results:
- RUNX2 expression positively correlated with CXCR4 levels in melanoma cells.
- Increased RUNX2 and CXCR4 expression enhanced markers of metastasis and autophagy.
- CXCR4 inhibition reduced osteotropism and modulated mTOR signaling.
Conclusions:
- RUNX2 transcription factor promotes melanoma progression by upregulating CXCR4.
- CXCR4 mediates melanoma cell invasion, autophagy, and osteotropism.
- Targeting CXCR4 may offer a therapeutic strategy for melanoma metastasis.
Related Concept Videos
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
01:06Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K